CN101757372A - Composition for treating osteoporosis and preparation method thereof - Google Patents

Composition for treating osteoporosis and preparation method thereof Download PDF

Info

Publication number
CN101757372A
CN101757372A CN200910232988A CN200910232988A CN101757372A CN 101757372 A CN101757372 A CN 101757372A CN 200910232988 A CN200910232988 A CN 200910232988A CN 200910232988 A CN200910232988 A CN 200910232988A CN 101757372 A CN101757372 A CN 101757372A
Authority
CN
China
Prior art keywords
parts
group
herba epimedii
add
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910232988A
Other languages
Chinese (zh)
Other versions
CN101757372B (en
Inventor
王琳
范淦彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Zelang Medical Technology Co Ltd
Original Assignee
Suzhou Paiteng Biomedical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Paiteng Biomedical Technology Co Ltd filed Critical Suzhou Paiteng Biomedical Technology Co Ltd
Priority to CN2009102329883A priority Critical patent/CN101757372B/en
Publication of CN101757372A publication Critical patent/CN101757372A/en
Application granted granted Critical
Publication of CN101757372B publication Critical patent/CN101757372B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a composition for treating osteoporosis which is prepared from the following raw materials in parts by weight: 5-10 parts of herba epimedii, 5-10 parts of scurfpea fruit, 1-3 parts of cuttlebone, 10-30 parts of radix astragali, 15-30 parts of yam and 5-30 parts of salvia miltiorrhiza. The composition has simple formula and accurate treatment effect on the osteoporosis. The invention also relates to a preparation method of the composition, which comprises the steps of: weighting the scurfpea fruit and crushing into fine powder for later use; weighting the herba epimedii, adding 80 percent alcohol with the weight of 8 times of the herba epimedii in volume and refluxing under the heating for 2 times, wherein each refluxing time is 1.5h; merging liquid medicines, filtering, decompressing and recovering the alcohol and concentrating to obtain concentrated liquor for later use; weighting the cuttlebone, the radix astragali, the yam and the salvia miltiorrhiza and adding water with the weight of 10 times of the total weight of the cuttlebone, the radix astragali, the yam and the salvia miltiorrhiza in volume for decocting for 2 times, wherein each decocting time is 2h; and merging decocting liquids, adding the reflux concentrated liquor, concentrating into thick paste, and adding the fine powder of the cuttlebone, and adding auxiliary materials to prepare a pharmaceutical acceptable preparation. Prepared by adopting the method, the composition is convenient to use and has controllable quality.

Description

A kind of composition and method of making the same for the treatment of osteoporosis
Technical field
The present invention relates to a kind of pharmaceutical composition and preparation method thereof, especially a kind of composition and method of making the same of forming by Chinese medicine.
Background technology
Osteoporosis (Osteoporosis) is a kind of common metabolic osteopathy that threatens healthy elder, shows as the components unchanged of bone, and bone content reduces, and bone micro-structure changes, and fracture risk increases.
The traditional Chinese medical science thinks that osteoporosis belongs to lumbago, asthenia, atrophic debility of bones category.
Primary disease is a kind of multi-pathogenesis disease, and its basic pathology mechanism is that defective appears in bone resorption and osteoplastic coupling connection in the bone metabolism process.In the existing known body circulation in multiple hormone, the bone metabolism some local modulation factors, physical training, physical factor and trophic factor etc. all may influence the process that bone metabolism and bone are built again.But in numerous links, how which kind of factors contribute interacts between each factor actually, remains further to be disclosed.
The traditional Chinese medical science thinks, the generation of osteoporosis disease mainly with deficiency of the kidney, insufficiency of the spleen, three factors of blood stasis are relevant.
Along with social senilization's process, osteoporosis disease has become a kind of commonly encountered diseases, and WHO classifies them one of as three big senile disease.Although research worker has been carried out a large amount of explorations to the pathomechanism and the Therapeutic Method of osteoporosis, clinical efficacy is still not good enough at present.Research is efficient, safe drugs are the major subjects of control primary disease.
Summary of the invention
Problem to be solved by this invention provides a kind of compositions for the treatment of osteoporosis, and its prescription is simplified, and is safe and effective, quality controllable.
Another technical problem to be solved by this invention provides a kind of preparation of compositions method, is made into modern preparation, the convenient use.
In order to solve the problems of the technologies described above, the present invention proposes following technical proposals:
A kind of compositions for the treatment of osteoporosis is characterized in that described compositions made by the raw material of following parts by weight: Herba Epimedii 5-10 part, Fructus Psoraleae 5-10 part, Endoconcha Sepiae 1-3 part, Radix Astragali 10-30 part, Rhizoma Dioscoreae 15-30 part, Radix Salviae Miltiorrhizae 5-15 part.
Prescription is preferably: 9 parts of Herba Epimedii, 9 parts of Fructus Psoraleaes, 2 parts of Endoconcha Sepiaes, 15 parts of the Radixs Astragali, 20 parts of Rhizoma Dioscoreaes, 10 parts of Radix Salviae Miltiorrhizaes.
Herba Epimedii is the dry aerial parts of Berberidaceae plant Herba Epimedii Epimedium brevicornum Maxim., arrow leaf Herba Epimedii Epimediumsagittatum (Sieb.et Zucc.) Maxim., pubescence Herba Epimedii Epimedium pubescens Maxim., Epimedium wushanense Epimedium wushanense T.S.Ying or Herba Epimedii Epimedium koreanum Nakai.
Fructus Psoraleae is the dry mature fruit of legumes psoraleae Psoralea corylifolia L..
Endoconcha Sepiae is the dry inner shell of Sepiidae animal sepiella maindroni de Rochebrune Sepiella maindroni de Rochebrune or golden cuttlefish Sepiaesculenta Hoyle.
The Radix Astragali is the dry root of leguminous plant Radix Astagali Astragalus membranaceus (Fisch.) Bge.var.mongho-licus (Bge.) Hsiao or Radix Astragali Astragalus membranaceus (Fisch.) Bge..
Rhizoma Dioscoreae is the dry rhizome of Dioscoreaceae plant Rhizoma Dioscoreae Dioscorea opposita Thunb..
Radix Salviae Miltiorrhizae is the dry root and rhizome of labiate Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..
Herba Epimedii, Fructus Psoraleae, Endoconcha Sepiae invigorating the kidney and strengthening the bones in the side, the Radix Astragali, Rhizoma Dioscoreae air making-up and spleen enlivening, the Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, all medicines share, and play the merit of invigorating the kidney and strengthening the bones, air making-up and spleen enlivening, blood circulation promoting and blood stasis dispelling altogether, can effectively prevent and treat osteoporosis.
The technique effect of traditional Chinese medicine composition for treating osteoporosis of the present invention can embody by following test.
Test example, the present composition are to the osteoporotic influence of castrated rats
1.1, test material
Medicine and reagent: the present composition, press the self-control of embodiment 13 methods; Synestrin tablets (1mg/ sheet), cod-liver oil (contains VD 35000 units/ml), calcium gluconate; Human serum estradiol (E2) radioimmunoassay determination box (Beijing nation decides Tyke Bioisystech Co., Ltd).
Animal: Healthy female Wistar rats, at 12 monthly ages, body weight is 250-320g, the Jiangsu Prov. Research Inst. Traditional Chinese Medical Experimental Animal Center provides.
Instrument: dual intensity X line bone densitometry instrument, DEXA (U.S.); The WD-1 type Material Testing Machine, Changchun experiment equipment factory; 724 spectrophotometers, the optical instrument factory, Shanghai.
1.2 test method
Method of emasculation: get healthy rat, anesthesia is extractd after the bilateral ovaries the 5th day by only carrying out vaginal smear examination, every day 1 time, continuous 5 days, gets ovariectomy and does not have fully emotionally that variation person's (castration group) is used for experiment.False castration treated animal operation is except that not extracing the ovary, and is surplus all with the castration group.
Female rats is got 10 castration groups that rehearse, and the passed examination animal is used for experiment after the remaining castration.Castrated rats is divided at random 10 every group.False castration group, castration group, all give normal saline, positive controls is irritated stomach and is given diethylstilbestrol 0.02mg/kg, cod-liver oil 450U/kg, calcium gluconate 0.5g/kg, high, medium and low dosage group is irritated stomach respectively and is given present composition 2.6g crude drug/kg, 5.2g crude drug/kg, 10.4g crude drug/kg, operation back beginning in the 9th day gastric infusion, every day 1 time, continuous three months, after the last administration, rat fasting 12h weighs.Behind the anesthetized animal, abdominal aortic blood is surveyed serum estradiol concentration, gets rat right side femur and measures bone density (BMD), gets the rats with left femur and measures bone biomechanical index (fracture load by bending, rigidity).Test data adopts t check carrying out statistical analysis between group.
1.3 result of the test
1.3.1 the present composition is to the influence of castrated rats femur density
Table 1 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00021
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Group Dosage (/Kg) Femur BMD (g/cm 2)
Group Dosage (/Kg) Femur BMD (g/cm 2)
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Present composition low dose group ??2.6g ??0.248±0.006*
Dosage group in the present composition ??5.2g ??0.251±0.007**
Present composition high dose group ??10.4g ??0.257±0.005**
Compare * P＜0.05 with the castration group; * P＜0.01, following table are together.
Result of the test shows, false castration group rat femur density is apparently higher than the castration group, and has highly significant meaning (p＜0.01), shows the modeling success.Compare positive controls, each dosage group rat femur density of the present composition obviously raise (p＜0.05,0.01) with the castration group.The above results shows, the present composition castrated rats bone density that can significantly raise.
1.3.2 the present composition is to the influence of castrated rats femur biomechanics
Table 2 present composition is to the influence of castrated rats femur biomechanics
Figure G2009102329883D00031
Group Dosage (/Kg) Fracture load by bending (N) Rigidity (N/mm)
The castration group ??- ??8.82±0.31 ??12.26±2.46
False castration group ??- ??10.25±0.44** ??18.27±2.66**
Positive controls ??(0.02mg+450U+0.5g) ??9.67±0.39** ??16.25±2.54**
Low dose group ??2.6g ??9.23±0.40* ??15.13±2.78*
Middle dosage group ??5.2g ??9.45±0.42** ??15.79±2.85**
High dose group ??10.4g ??9.70±0.38** ??16.40±3.02**
Result of the test shows, false castration group rat femur fracture load by bending, rigidity is apparently higher than the castration group, and all has highly significant meaning (p＜0.01), shows the modeling success.Compare with the castration group, positive controls, each dosage group rat femur fracture load by bending of the present composition, rigidity is obviously rising (p＜0.05,0.01) all.
1.3.3 the present composition is to the influence of castrated rats serum E2 concentration
Table 3 present composition is to the influence of castrated rats serum E2 concentration
Figure G2009102329883D00032
Group Dosage (/Kg) Serum E2 concentration (pg/ml)
The castration group ??- ??40.1±15.5
False castration group ??- ??70.9±10.2**
Positive controls ??(0.02mg+450U+0.5g) ??65.8±13.4**
Present composition low dose group ??2.6g ??54.9±12.9*
Dosage group in the present composition ??5.2g ??59.2±10.6**
Present composition high dose group ??10.4g ??64.1±11.1**
Result of the test shows, false castration group rat blood serum estradiol (E2) concentration is apparently higher than the castration group, and has highly significant meaning (p＜0.01), shows the modeling success.Compare with the castration group, positive controls, each dosage group rat blood serum estradiol (E2) concentration of the present composition obviously raise, and have highly significant meaning (p＜0.05,0.01).
In sum, the present composition can significantly strengthen the bone density of castrated rats, improves its bone biomechanical index, its serum estradiol (E2) concentration that raises, and above-mentioned effect is the pharmacological basis of its treatment osteoporosis.
The preparation method of the present composition is: gets Endoconcha Sepiae, is ground into fine powder, and standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add adjuvant, make the acceptable preparation of pharmacy.
The dosage form of the present composition adopts peroral dosage form, is selected from a kind of in granule, sheet, capsule, drop pill, the soft capsule.
When Chinese medicine composition of the present invention is used for the treatment of osteoporosis, different according to the state of an illness and occupation mode, daily crude drug amount is 10-100g.
Technical scheme of the present invention hereinafter will do further statement, but the scope of protection of present invention is not limited to following embodiment in order better to illustrate to its specific embodiment.
The specific embodiment
Embodiment 1
Prescription: Herba Epimedii 717g, Fructus Psoraleae 1434g, Endoconcha Sepiae 430g, Radix Astragali 4301g, Rhizoma Dioscoreae 4301g, Radix Salviae Miltiorrhizae 2151g (being equivalent to 5: 10: 3: 30: 30: 15).
Method for making: get Endoconcha Sepiae, be ground into fine powder, standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add starch, sodium carboxymethyl cellulose is an amount of, the system granule, the encapsulating capsule is made 1000.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 6.4g crude drug/kg, and result of the test sees the following form:
Table 4 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00041
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 1 ??6.4g ??0.249±0.006*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 2
Prescription: Herba Epimedii 1630g, Fructus Psoraleae 815g, Endoconcha Sepiae 163g, Radix Astragali 1630g, Rhizoma Dioscoreae 2446g, Radix Salviae Miltiorrhizae 815g (being equivalent to 10: 5: 1: 10: 15: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 3.6g crude drug/kg, and result of the test sees the following form:
Table 5 present composition is to the influence of castrated rats femur density
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 2 ??3.6g ??0.248±0.005*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 3
Prescription: Herba Epimedii 1344g, Fructus Psoraleae 672g, Endoconcha Sepiae 403g, Radix Astragali 4032g, Rhizoma Dioscoreae 4032g, Radix Salviae Miltiorrhizae 2016g (being equivalent to 10: 5: 3: 30: 30: 15)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 6.0g crude drug/kg, and result of the test sees the following form:
Table 6 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00052
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 3 ??6.0g ??0.248±0.005*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 4
Prescription: Herba Epimedii 815g, Fructus Psoraleae 1630g, Endoconcha Sepiae 163g, Radix Astragali 1630g, Rhizoma Dioscoreae 2446g, Radix Salviae Miltiorrhizae 815g (being equivalent to 5: 10: 1: 10: 15: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 3.6g crude drug/kg, and result of the test sees the following form:
Table 7 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00061
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 4 ??3.6g ??0.247±0.004*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 5
Prescription: Herba Epimedii 1389g, Fructus Psoraleae 1389g, Endoconcha Sepiae 139g, Radix Astragali 4167g, Rhizoma Dioscoreae 4167g, Radix Salviae Miltiorrhizae 2083g (being equivalent to 10: 10: 1: 30: 30: 15)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 6.4g crude drug/kg, and result of the test sees the following form:
Table 8 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00062
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 5 ??6.4g ??0.252±0.009**
Result of the test shows, compares can obviously the raise femur density (p＜0.01) of rat of present embodiment compositions group with the castration group.
Embodiment 6
Prescription: Herba Epimedii 872g, Fructus Psoraleae 872g, Endoconcha Sepiae 523g, Radix Astragali 1744g, Rhizoma Dioscoreae 2616g, Radix Salviae Miltiorrhizae 872g (being equivalent to 5: 5: 3: 10: 15: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2.
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 3.6g crude drug/kg, and result of the test sees the following form:
Table 9 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00071
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 6 ??3.6g ??0.249±0.008*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 7
Prescription: Herba Epimedii 1282g, Fructus Psoraleae 1282g, Endoconcha Sepiae 385g, Radix Astragali 1282g, Rhizoma Dioscoreae 3846g, Radix Salviae Miltiorrhizae 1923g (being equivalent to 10: 10: 3: 10: 30: 15)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 4.8g crude drug/kg, and result of the test sees the following form:
Table 10 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00072
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 7 ??4.8g ??0.251±0.010*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 8
Prescription: Herba Epimedii 820g, Fructus Psoraleae 820g, Endoconcha Sepiae 164g, Radix Astragali 4918g, Rhizoma Dioscoreae 2459g, Radix Salviae Miltiorrhizae 820g (being equivalent to 5: 5: 1: 30: 15: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 4.8g crude drug/kg, and result of the test sees the following form:
Table 11 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00073
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Group Dosage (/Kg) Femur BMD (g/cm 2)
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 8 ??4.8g ??0.249±0.006*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 9
Prescription: Herba Epimedii 1305g, Fructus Psoraleae 1305g, Endoconcha Sepiae 392g, Radix Astragali 3916g, Rhizoma Dioscoreae 1958g, Radix Salviae Miltiorrhizae 1958g (being equivalent to 10: 10: 3: 30: 15: 15)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 5.2g crude drug/kg, and result of the test sees the following form:
Table 12 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00081
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 9 ??5.2g ??0.251±0.007**
Result of the test shows, compares can obviously the raise femur density (p＜0.01) of rat of present embodiment compositions group with the castration group.
Embodiment 10
Prescription: Herba Epimedii 818g, Fructus Psoraleae 818g, Endoconcha Sepiae 164g, Radix Astragali 1637g, Rhizoma Dioscoreae 4911g, Radix Salviae Miltiorrhizae 818g (being equivalent to 5: 5: 1: 10: 30: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 4.4g crude drug/kg, and result of the test sees the following form:
Table 13 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00082
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 10 ??4.4g ??0.253±0.009**
Result of the test shows, compares can obviously the raise femur density (p＜0.01) of rat of present embodiment compositions group with the castration group.
Embodiment 11
Prescription: Herba Epimedii 1326g, Fructus Psoraleae 1326g, Endoconcha Sepiae 398g, Radix Astragali 3977g, Rhizoma Dioscoreae 3977g, Radix Salviae Miltiorrhizae 663g (being equivalent to 10: 10: 3: 30: 30: 5)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 5.6g crude drug/kg, and result of the test sees the following form:
Table 14 present composition is to the influence of castrated rats femur density
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 11 ??5.6g ??0.248±0.006*
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 12
Prescription: Herba Epimedii 899g, Fructus Psoraleae 899g, Endoconcha Sepiae 180g, Radix Astragali 1797g, Rhizoma Dioscoreae 2696g, Radix Salviae Miltiorrhizae 2696g (being equivalent to 5: 5: 1: 10: 15: 15)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2
Pharmacological testing: with reference to the test example, present embodiment compositions dosage is 4.4g crude drug/kg, and result of the test sees the following form:
Table 15 present composition is to the influence of castrated rats femur density
Figure G2009102329883D00092
Group Dosage (/Kg) Femur BMD (g/cm 2)
The castration group ??- ??0.241±0.007
False castration group ??- ??0.278±0.005**
Positive controls ??(0.02mg+450U+0.5g) ??0.255±0.005**
Embodiment 12 ??4.4g ??0.247±0.005**
Result of the test shows, compares can obviously the raise femur density (p＜0.05) of rat of present embodiment compositions group with the castration group.
Embodiment 13
Prescription: Herba Epimedii 1500g, Fructus Psoraleae 1500g, Endoconcha Sepiae 333g, Radix Astragali 2500g, Rhizoma Dioscoreae 3333g, Radix Salviae Miltiorrhizae 1667g (being equivalent to 9: 9: 2: 15: 20: 10)
Method for making: with embodiment 1.
Usage: every day 3 times, each 2.
Embodiment 14
Prescription: Herba Epimedii 1500g, Fructus Psoraleae 1500g, Endoconcha Sepiae 333g, Radix Astragali 2500g, Rhizoma Dioscoreae 3333g, Radix Salviae Miltiorrhizae 1667g (being equivalent to 9: 9: 2: 15: 20: 10)
Method for making: get Endoconcha Sepiae, be ground into fine powder, standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add starch, sodium carboxymethyl cellulose is an amount of, the system granule, tabletting is made 1000.
Usage: every day 3 times, each 2.
Embodiment 15
Prescription: Herba Epimedii 1500g, Fructus Psoraleae 1500g, Endoconcha Sepiae 333g, Radix Astragali 2500g, Rhizoma Dioscoreae 3333g, Radix Salviae Miltiorrhizae 1667g (being equivalent to 9: 9: 2: 15: 20: 10)
Method for making: get Endoconcha Sepiae, be ground into fine powder, standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add starch, the system granule is made 1000g.
Usage: every day 3 times, each 2g.
Embodiment 16
Prescription: Herba Epimedii 1500g, Fructus Psoraleae 1500g, Endoconcha Sepiae 333g, Radix Astragali 2500g, Rhizoma Dioscoreae 3333g, Radix Salviae Miltiorrhizae 1667g (being equivalent to 9: 9: 2: 15: 20: 10)
Method for making: get Endoconcha Sepiae, be ground into fine powder, standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, it is an amount of to add Polyethylene Glycol, and mixing drips the system drop pill and becomes 3000.
Usage: every day 3 times, each 6.
Embodiment 17
Prescription: Herba Epimedii 1500g, Fructus Psoraleae 1500g, Endoconcha Sepiae 333g, Radix Astragali 2500g, Rhizoma Dioscoreae 3333g, Radix Salviae Miltiorrhizae 1667g (being equivalent to 9: 9: 2: 15: 20: 10)
Method for making: get Endoconcha Sepiae, be ground into fine powder, standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, adding 10 times of amounts of its gross weight volume decocting boils 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add soybean oil, paraffin is an amount of, mixing, the compacting soft capsule becomes 1000.
Usage: every day 3 times, each 2.

Claims (5)

1. compositions for the treatment of osteoporosis is characterized in that described compositions made by the raw material of following parts by weight: Herba Epimedii 5-10 part, Fructus Psoraleae 5-10 part, Endoconcha Sepiae 1-3 part, Radix Astragali 10-30 part, Rhizoma Dioscoreae 15-30 part, Radix Salviae Miltiorrhizae 5-15 part.
2. according to the compositions of the described treatment osteoporosis of claim 1, it is characterized in that said composition made by the raw material of following parts by weight: 9 parts of Herba Epimedii, 9 parts of Fructus Psoraleaes, 2 parts of Endoconcha Sepiaes, 15 parts of the Radixs Astragali, 20 parts of Rhizoma Dioscoreaes, 10 parts of Radix Salviae Miltiorrhizaes.
3. the preparation of compositions method of the described treatment osteoporosis of claim 1 is characterized in that described method comprises the following steps: to get Endoconcha Sepiae, is ground into fine powder, and is standby; Get Herba Epimedii, add 80% alcohol heating reflux 2 times of 8 times of its weight amount volume, each 1.5 hours, merge medicinal liquid, filter, decompression recycling ethanol also concentrates, and concentrated solution is standby; Get Fructus Psoraleae, the Radix Astragali, Rhizoma Dioscoreae, Radix Salviae Miltiorrhizae 4 flavor medical materials, add 10 times of amounts of its gross weight volume decocting and boil 2 times, each 2 hours, merge decoction liquor, filter, add above-mentioned backflow concentrated solution, be concentrated into the thick paste shape, add the Endoconcha Sepiae fine powder, add adjuvant, make the acceptable preparation of pharmacy.
4. according to the preparation of compositions method of the described treatment osteoporosis of claim 3, it is characterized in that the dosage form of described preparation adopts peroral dosage form.
5. according to the preparation of compositions method of the described treatment osteoporosis of claim 4, it is characterized in that described peroral dosage form is selected from a kind of in granule, sheet, capsule, drop pill, the soft capsule.
CN2009102329883A 2009-10-20 2009-10-20 Composition for treating osteoporosis and preparation method thereof Active CN101757372B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102329883A CN101757372B (en) 2009-10-20 2009-10-20 Composition for treating osteoporosis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102329883A CN101757372B (en) 2009-10-20 2009-10-20 Composition for treating osteoporosis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101757372A true CN101757372A (en) 2010-06-30
CN101757372B CN101757372B (en) 2012-01-11

Family

ID=42488856

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102329883A Active CN101757372B (en) 2009-10-20 2009-10-20 Composition for treating osteoporosis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101757372B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772486A (en) * 2012-07-31 2012-11-14 泰安大凡神农制药有限公司 Traditional Chinese medicine preparation for preventing osteoporosis and preparation method for traditional Chinese medicine preparation
CN103239590A (en) * 2013-04-23 2013-08-14 江苏济川制药有限公司 Traditional Chinese medicine composition as well as preparation and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148213C (en) * 2001-02-06 2004-05-05 四川省中药研究所 Composite medicine for treating osteoporosis
CN101138597B (en) * 2007-08-31 2010-06-23 澳门科技大学 Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
CN101361893B (en) * 2008-09-16 2010-11-03 东莞市赫尔逊生物科技有限公司 Traditional Chinese medicine combination for preventing and treating osteoporosis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772486A (en) * 2012-07-31 2012-11-14 泰安大凡神农制药有限公司 Traditional Chinese medicine preparation for preventing osteoporosis and preparation method for traditional Chinese medicine preparation
CN103239590A (en) * 2013-04-23 2013-08-14 江苏济川制药有限公司 Traditional Chinese medicine composition as well as preparation and application thereof

Also Published As

Publication number Publication date
CN101757372B (en) 2012-01-11

Similar Documents

Publication Publication Date Title
CN100348263C (en) Chinese medicine preparation for treating male sterility
CN101513437B (en) Antifatigue Chinese pharmaceutical composition and preparation method thereof
CN101869665B (en) Chinese medicinal composition for treating necrospermia, asthenospermia oligospermia, or aspermatism
CN1323699C (en) Externally applied plaster for treating Bi syndrome and preparation method thereof
CN101269170B (en) Medicament for treating climacteric syndrome and preparation method thereof
CN104984297A (en) Application of pharmaceutical composition in preparation of drugs for treating amenorrhea
CN101007138B (en) Drug for treating male infertility
CN106266558A (en) A kind of Halth-care composition of resisting fatigue and preparation method thereof
CN101757322A (en) Vegetable drug compound preparation for treating urarthritis as well as preparation and application thereof
CN101023982B (en) Medicine composition for treating osteoporosis
CN104547750A (en) Traditional Chinese medicine composition for treating senile osteoporosis
CN109528980A (en) A kind of Chinese medicine composition and its pharmacy application for treating Ovary reserve decline disease
CN101757372B (en) Composition for treating osteoporosis and preparation method thereof
CN101138597B (en) Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
CN101095768A (en) Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
CN100528220C (en) Gynecological Chinese patented medicine for relieving depressed liver and clearing heat, strengthening spleen and nourishing blood and its preparing method
CN104688932A (en) Traditional Chinese medicine preparation for postmenopausal osteoporosis and preparation method
CN105267559B (en) A kind of drug and preparation method thereof for treating diabete peripheral herve pathology
CN1122518C (en) Medicine for curing gynecopathy
CN101380387A (en) Composition for treating climacteric metancholia and preparation method thereof
CN1086144C (en) Capsule for tonifying kidney
CN102293923A (en) Application of Tibetan medicinal composition to preparation of medicament for preventing and treating osteoporosis
CN1107517C (en) Antiabortifacient for treating acyesis and sterility and its preparing process
CN101829222B (en) Traditional Chinese medicine for preventing and treating premature ovarian failure after hysterectomy
CN101455717A (en) Traditional Chinese medicine composition for treating osteoporosis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: LIU DONGFENG

Free format text: FORMER OWNER: SUZHOU PAITENG BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.

Effective date: 20120724

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 215011 SUZHOU, JIANGSU PROVINCE TO: 210049 NANJING, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20120724

Address after: 210049, Jiangsu, Qixia Nanjing Ring Road No. 1, Tian Hong villa, Songshan court, 1, 402

Patentee after: Liu Dongfeng

Address before: Suzhou City, Jiangsu Province, 215011 Suzhou high tech Development Zone Sunshine Holiday Garden Building 63, No. 1412

Patentee before: Suzhou Paiteng Biopharmaceutical Technology Co., Ltd.

ASS Succession or assignment of patent right

Owner name: NANJING ZELANG PHARMACEUTICAL TECHNOLOGY INC.

Free format text: FORMER OWNER: LIU DONGFENG

Effective date: 20130110

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 210049 NANJING, JIANGSU PROVINCE TO: 210046 NANJING, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130110

Address after: 210046, Jiangsu, Qixia province Nanjing Yao street, Gan family, No. 108, Hong Kong port science and technology innovation center 05, building 6

Patentee after: Nanjing Zelang Medical Technology Co., Ltd.

Address before: 210049, Jiangsu, Qixia province Nanjing Ring Road No. 1, Tian Hong villa, Songshan court, 1, 402

Patentee before: Liu Dongfeng